America fell into the hole it dug for India! Trump's secrets exposed in a new report

Donald Trump is planning to impose heavy tariffs on imports from India and China to promote drug manufacturing in America, but according to experts, this self-reliance is not easy. Even if drug companies invest in America, the raw material will still come from abroad. The cost will be high and the medicines will not be cheap, which will increase the burden on the common people.

US President Donald Trump has once again shown his attitude. He has warned of imposing tax or tariff on import of medicines from many countries of the world. Trump wants America to now manufacture the medicines it needs itself. Trump is especially targeting India and China in this, because both these countries play an important role in America's medicine supply chain. Trump claims that this will increase America's confidence in the production of medicines in its country and will strengthen national security. But the report shows that America has now got trapped in the process of harassing India.

Big companies are making huge investments

After this threat from Trump, big pharmaceutical companies have talked about expanding their factories in America. According to a CNN report, AstraZeneca will invest $50 billion in America. Johnson & Johnson is planning to invest $55 billion. Eli Lilly is planning to invest $27 billion. Overall, pharmaceutical companies are planning to invest about $250 billion in America. Trump says that these steps are necessary for the security of the country and to reduce the price of medicines, but according to the report, even after doing all this, the prices of medicines are not going to come down.

Will America really be able to become self-sufficient?

Experts believe that the matter is not so easy. Only a factory is not enough to make a medicine, but the raw material used in it is the most important and even today America imports this raw material from abroad. This means that even if America manufactures medicines here, it will have to get the raw material from India, China or other countries. Apart from this, making medicines in America is not cheap. There, the cost of everything from labor to machinery and electricity is high. This means that even if the medicine is made in America, it will put more burden on the pocket of the common man.

Companies do not want to make generic medicines

Some companies have talked about making generic medicines in America but most companies are away from it. The reason for this is that the profit on generic medicines is very low. In such a situation, companies fear that by setting up a factory in America they will only incur losses and they will not be able to bear these losses. Currently, about 90 percent of the medicines that are written on doctors' prescriptions in America are generic and most of these come from abroad, especially from India.

Local production is not easy, it will cost a lot

Experts say that if America has to become self-sufficient in the pharmaceutical sector, then the government will have to provide huge financial aid. Otherwise, companies will back off from investing in America. Trump has indicated that he can impose a 200% tax on medicines but before that he will also give companies 1 years’ time so that they can prepare.

Nevertheless, experts believe that it will take at least 3 to 5 years for new factories to be built and started. Also, the cost of manufacturing medicines in America will be high, due to which medicines will not be cheap. On top of this, if the raw material has to be imported, then tax will be levied on that as well, which means that overall it is certain to affect the pockets of common people. Along with this, there is also a danger of many pharmaceutical companies going bankrupt. This plan of Trump may sound good only in hearing, but it is very difficult to implement it on the ground.

PC:TV9Bharatvarsh